CRSP
CRISPR Therapeutics AG
Stock
$55.43−0.01 (−0.02%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $13M | +37.3% |
| Operating income | −$534M | — |
| Net income | −$451M | — |
| EPS | −$4.76 | — |
| Free cash flow | −$371M | — |
CRISPR Therapeutics AG
$55.43−0.01 (−0.02%)Close Oct 2, 2026
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $13M | +37.3% |
| Operating income | −$534M | — |
| Net income | −$451M | — |
| EPS | −$4.76 | — |
| Free cash flow | −$371M | — |